受强制性开放获取政策约束的文章 - Panagiotis Kottaridis了解详情
无法在其他位置公开访问的文章：6 篇
Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell–depleted allogeneic transplantation for Hodgkin …
KS Peggs, I Kayani, N Edwards, P Kottaridis, AH Goldstone, DC Linch, ...
Journal of Clinical Oncology 29 (8), 971-978, 2011
强制性开放获取政策： Cancer Research UK
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission
J Othman, N Potter, A Ivey, J Jovanovic, M Runglall, SD Freeman, ...
Blood 143 (19), 1931-1936, 2024
强制性开放获取政策： Cancer Research UK
Cytomegalovirus pre‐emptive therapy after hematopoietic stem cell transplantation in the era of real‐time quantitative PCR: comparison with recipients of solid organ transplants
E Panagou, G Zakout, J Keshani, C Smith, D Irish, S Mackinnon, ...
Transplant Infectious Disease 18 (3), 405-414, 2016
强制性开放获取政策： Wellcome Trust
Dual Glutathione‐S‐Transferase‐θ1 and ‐μ1 Gene Deletions Determine Imatinib Failure in Chronic Myeloid Leukemia
A Davies, A Giannoudis, JE Zhang, G Austin, L Wang, TL Holyoake, ...
Clinical Pharmacology & Therapeutics 96 (6), 694-703, 2014
强制性开放获取政策： Cancer Research UK, UK Medical Research Council, National Institute for …
Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML
J Othman, N Potter, A Ivey, Y Tazi, E Papaemmanuil, J Jovanovic, ...
Blood, 2024
强制性开放获取政策： Cancer Research UK
Genomic correlates of outcome in a randomised comparison of CPX-351 and FLAG-Ida in high-risk acute myeloid leukaemia and myelodysplastic syndrome: results from the UK NCRI …
J Othman, R Dillon, C Wilhelm-Benartzi, S Knapper, LM Batten, J Canham, ...
Blood 140 (Supplement 1), 1036-1038, 2022
强制性开放获取政策： Cancer Research UK
可在其他位置公开访问的文章：12 篇
The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia
A Giannoudis, L Wang, AL Jorgensen, G Xinarianos, A Davies, ...
Blood, The Journal of the American Society of Hematology 121 (4), 628-637, 2013
强制性开放获取政策： Cancer Research UK
Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency
TA Fox, R Chakraverty, S Burns, B Carpenter, K Thomson, D Lowe, ...
Blood, The Journal of the American Society of Hematology 131 (8), 917-931, 2018
强制性开放获取政策： Blood Cancer UK, Cancer Research UK, UK Medical Research Council, National …
Wilms’ Tumour 1 (WT 1) peptide vaccination in patients with acute myeloid leukaemia induces short‐lived WT 1‐specific immune responses
B Uttenthal, I Martinez‐Davila, A Ivey, C Craddock, F Chen, A Virchis, ...
British journal of haematology 164 (3), 366-375, 2014
强制性开放获取政策： UK Medical Research Council
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML
J Othman, N Potter, K Mokretar, D Taussig, A Khan, P Krishnamurthy, ...
Leukemia 37 (10), 2066-2072, 2023
强制性开放获取政策： Blood Cancer UK, Cancer Research UK, National Institute for Health Research, UK
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3‐mutated acute myeloid leukaemia and severe COVID‐19
AJ Wilson, E Troy‐Barnes, M Subhan, F Clark, R Gupta, AK Fielding, ...
British Journal of Haematology 190 (4), e189, 2020
强制性开放获取政策： Cancer Research UK
A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: The UK NCRI AML19 trial
J Othman, C Wilhelm-Benartzi, R Dillon, S Knapper, SD Freeman, ...
Blood Advances 7 (16), 4539-4549, 2023
强制性开放获取政策： Cancer Research UK
Fludarabine, Cytarabine, Granulocyte colony-stimulating factor, and Idarubicin with Gemtuzumab Ozogamicin improves event-free survival in younger patients with newly diagnosed …
NH Russell, C Wilhelm-Benartzi, J Othman, R Dillon, S Knapper, ...
Journal of Clinical Oncology 42 (10), 1158-1168, 2024
强制性开放获取政策： Cancer Research UK
A randomised evaluation of low‐dose cytosine arabinoside (ara‐C) plus tosedostat versus low‐dose ara‐C in older patients with acute myeloid leukaemia: results …
M Dennis, A Burnett, R Hills, I Thomas, C Ariti, MT Severinsen, ...
British Journal of Haematology 194 (2), 298-308, 2021
强制性开放获取政策： Blood Cancer UK, Cancer Research UK, UK Medical Research Council, National …
Natural History of Epstein-Barr Virus Replication and Viral Load Dynamics after Alemtuzumab-Based Allogeneic Stem Cell Transplantation
MAV Marzolini, AJ Wilson, E Sanchez, B Carpenter, R Chakraverty, ...
Transplantation and Cellular Therapy 27 (8), 682. e1-682. e12, 2021
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK
Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel …
LJ Estcourt, ZK McQuilten, P Bardy, M Cole-Sinclair, GP Collins, ...
The Lancet Haematology, 2024
强制性开放获取政策： National Health and Medical Research Council, Australia
Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trial
BH Mullish, AJ Innes, LA Roberts, S Anim-Burton, L Webber, NA Johnson, ...
BMJ Open 14 (12), e093120, 2024
强制性开放获取政策： UK Medical Research Council, National Institute for Health Research, UK
Intensive Chemotherapy Is Associated With Poor Overall Survival in Autoimmune Disease-associated Myeloid Malignancies
SE Richardson, D Brian, V Grandage, R Hough, P Kottaridis, MR Mansour, ...
HemaSphere 3 (1), e164, 2019
强制性开放获取政策： Blood Cancer UK, Cancer Research UK, National Institute for Health Research, UK
出版信息和资助信息由计算机程序自动确定